`
`;
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF NEW JERSEY
`
`JAZZ PHARMACEUTICALS, INC.,
`
`Plaintiff,
`
`v.
`
`C.A. No. 13-cv-391-ES-JAD
`Consolidated
`
`AMNEAL PHARMACEUTICALS LLC et al.,
`
`Defendants.
`
`ORDER GRANTING MOTION
`TO SEAL
`
`Document Filed Electronically
`
`THIS MATTER having been opened to the Court by Plaintiff Jazz Pharmaceuticals, Inc.
`
`("Jazz"), by and through its counsel, in connection with Jazz's Motion to Seal (ECF No. 199),
`
`pursuant to Local Civil Rule 5.3(c); and the Court having considered the papers submitted by
`
`Jazz in support of its Motion; and papers submitted by Defendant Par Pharmaceutical, Inc.
`
`("Par") in further support thereof (ECF No 212); and the Court having been notified by Par of
`
`the information that Par has designated Highly Confidential; and the Court having considered
`
`the Declaration of Bradford C. Frese, counsel for Par, and adopted the Findings of Fact and
`
`Conclusions of Law submitted by Par in further support of Jazz's Motion to Seal (ECF No.
`
`212-2); and the Court having further found that the standards of Local Civil Rule 5.3(c)(2) have
`
`been met and support the sealing of portions of Jazz's January 12, 2016 letter to the undersigned
`
`(ECF No. 198); and for good cause having been shown,
`~\
`IT IS on this \~==day of ~~ c~ 2016;
`
`ORDERED that Jazz's Motion to Seal portions of its January 12, 2016 letterpursuant
`
`to Local Civil Rule 5.3(c), (ECF No. 199), is hereby GRANTED; and it is further
`
`ORDERED that the unredacted version of Jazz's January 12, 2016 letter, (ECF No.
`
`198), shall remain sealed; and it is further
`
`i
`
`'
`
`
`
`Case 2:13-cv-00391-ES-JAD Document 235 Filed 03/18/16 Page 2 of 2 PageID: 4588
`
`ORDERED that, on or before April 1, 2016, Jazz shall publicly file a redacted version
`
`of its January 12, 2016 submission (as an attachment to an explanatory cover letter) in which
`
`only the confidential information in question has been redacted.
`
`HONo~cK:oN
`
`UNITED STATES MAGISTRATE JUDGE
`
`2
`
`